Primary lung cancer after treatment of head and neck cancer without lymph node metastasis: Is there a role for autofluorescence bronchoscopy?

Lung Cancer

Volumn 62, Issue 3, 2008, Pages 309-315

  Lee, Pyng ^a   de Bree, Remco ^a   Brokx, Hes A P ^a   Leemans, C René ^a   Postmus, Pieter E ^a   Sutedja, Tom G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autofluorescence bronchoscopy; Head and neck cancer; Lung cancer; Survival

Indexed keywords

ADULT; AGED; ARTICLE; AUTOFLUORESCENCE; BRACHYTHERAPY; BRONCHOSCOPY; CANCER PATIENT; CANCER SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; SMOKING;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADULT; AGED; BRONCHOSCOPY; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORESCENCE; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; PROSPECTIVE STUDIES; SMALL CELL LUNG CARCINOMA; SMOKING; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 56949101219     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.03.034     Document Type: Article

References (32)

1. Sankaranarayanan R., Masuyer E., Swaminathan R., Ferlay J., and Whelan S. Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res 18 6B (1998) 4779-4786
2. Vereniging van Intergrale Kankercentra (VIKC), Utrecht. URL: http://www.ikcnet.nl.
3. Dhooge I.J., De Vos M., and Van Cauwenberge P.B. Multiple primary malignant tumors in patients with head and neck cancer: results of a prospective study and future perspectives. Laryngoscope 108 2 (1998) 250-256
4. Dikshit R.P., Boffetta P., Bouchardy C., Merletti F., Crosignani P., Cuchi T., et al. Risk factors for the development of second primary tumors among men after laryngeal and hypopharyngeal carcinoma. Cancer 103 11 (2005) 2326-2333
5. Licciardello J.T., Spitz M.R., and Hong W.K. Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung. Int J Radiat Oncol Biol Phys 17 3 (1989) 467-476
6. Buwalda J., Zuur C.L., Lubsen H., Tijssen J.G., Koole R., and Hordijk G.J. Annual chest X-ray in patients after treatment for laryngeal or oral cancer: only a limited number of second primary lung cancers detected. Ned Tijdschr Geneeskd 143 29 (1999) 1517-1522
7. Braakhuis B.J., Tabor M.P., Kummer J.A., Leemans C.R., and Brakenhoff R.H. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 63 8 (2003) 1727-1730
8. Davidson J., Briant D., Gullane P., Keane T., and Rawlinson E. The role of surgery following radiotherapy failure for advanced laryngopharyngeal cancer. A prospective study. Arch Otolaryngol Head Neck Surg 120 3 (1994) 269-276
9. Ritoe S.C., Krabbe P.F., Jansen M.M., Festen J., Joosten F.B., Kaanders J.H., et al. Screening for second primary lung cancer after treatment of laryngeal cancer. Laryngoscope 112 11 (2002) 2002-2008
10. Ritoe S.C., Krabbe P.F., Kaanders J.H., van den Hoogen F.J., Verbeek A.L., and Marres H.A. Value of routine follow-up for patients cured of laryngeal carcinoma. Cancer 101 6 (2004) 1382-1389
11. Boysen M., Lovdal O., Tausjo J., and Winther F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 28 2-3 (1992) 426-430
12. Haas I., Hauser U., and Ganzer U. The dilemma of follow-up in head and neck cancer patients. Eur Arch Otorhinolaryngol 258 4 (2001) 177-183
13. Warren S., and Gates O. Multiple primary malignant tumors: a survey of the literature and a statistical study. Am J Cancer 51 (1932) 1358-1403
14. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 1995;152:S77-121.
15. Braakhuis B.J., Tabor M.P., Leemans C.R., van dW I., Snow G.B., and Brakenhoff R.H. Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck 24 2 (2002) 198-206
16. Tabor M.P., Brakenhoff R.H., Ruijter-Schippers H.J., Van Der Wal J.E., Snow G.B., Leemans C.R., et al. Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 161 3 (2002) 1051-1060
17. Brouha X., Tromp D., Hordijk G.J., Winnubst J., and De Leeuw R. Role of alcohol and smoking in diagnostic delay of head and neck cancer patients. Acta Otolaryngol 125 5 (2005) 552-556
18. Do K.A., Johnson M.M., Lee J.J., Wu X.F., Dong Q., Hong W.K., et al. Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies. Cancer 101 12 (2004) 2837-2842
19. Haughey B.H., Gates G.A., Arfken C.L., and Harvey J. Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 101 2 Pt 1 (1992) 105-112
20. Benninger M.S., Shariff A., and Blazoff K. Symptom-directed selective endoscopy: long-term efficacy. Arch Otolaryngol Head Neck Surg 127 7 (2001) 770-773
21. Narayana A., Vaughan A.T., Fisher S.G., and Reddy S.P. Second primary tumors in laryngeal cancer: results of long-term follow-up. Int J Radiat Oncol Biol Phys 42 3 (1998) 557-562
22. Bach P.B., Kattan M.W., Thornquist M.D., Kris M.G., Tate R.C., Barnett M.J., et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 95 6 (2003) 470-478
23. Patel J.D. Lung cancer in women. J Clin Oncol 23 14 (2005) 3212-3218
24. Shriver S.P., Bourdeau H.A., Gubish C.T., Tirpak D.L., Davis A.L., Luketich J.D., et al. Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer. J Natl Cancer Inst 92 1 (2000) 24-33
25. Hirsch F.R., Prindiville S.A., Miller Y.E., Franklin W.A., Dempsey E.C., Murphy J.R., et al. Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study. J Natl Cancer Inst 93 18 (2001) 1385-1391
26. Lam S., Kennedy T., Unger M., Miller Y.E., Gelmont D., Rusch V., et al. Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy. Chest 113 3 (1998) 696-702
27. Pasic A., Vonk-Noordegraaf A., Risse E.K., Postmus P.E., and Sutedja T.G. Multiple suspicious lesions detected by autofluorescence bronchoscopy predict malignant development in the bronchial mucosa in high risk patients. Lung Cancer 41 3 (2003) 295-301
28. Ha P.K., Hdeib A., Goldenberg D., Jacene H., Patel P., Koch W., et al. The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 132 1 (2006) 12-16
29. Schoder H., Yeung H.W., Gonen M., Kraus D., and Larson S.M. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 231 1 (2004) 65-72
30. Zanation A.M., Sutton D.K., Couch M.E., Weissler M.C., Shockley W.W., and Shores C.G. Use, accuracy, and implications for patient management of [18F]-2-fluorodeoxyglucose-positron emission/computerized tomography for head and neck tumors. Laryngoscope 115 7 (2005) 1186-1190
31. Pillot G., Siegel B.A., and Govindan R. Prognostic value of fluorodeoxyglucose positron emission tomography in non-small cell lung cancer: a review. J Thorac Oncol 1 2 (2006) 152-159
32. Potti A., Mukherjee S., Petersen R., Dressman H.K., Bild A., Koontz J., et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 355 6 (2006) 570-580